Inari Medical Inc (NAS:NARI)
$ 50 -0.69 (-1.36%) Market Cap: 2.91 Bil Enterprise Value: 2.88 Bil PE Ratio: 0 PB Ratio: 6.57 GF Score: 72/100

Inari Medical Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 12:10PM GMT
Release Date Price: $81.79 (+5.85%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Great. Good morning, and thank you, and looking forward to kicking off Morgan Stanley Healthcare Conference. First day, first presentation, excited to have Inari Medical with us. Drew Hykes, COO; Bill Hoffman, CEO currently. We can touch on that. Tom Tu, CMO; and Mitch Hill, CFO. But again, thank you to all of you for being here. Really excited to have you first day at the conference.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

And I wanted to start off just really with the management transition. I think, Bill, you've gotten a lot of questions in terms of why now, why it's the right time? And thinking back to the time to the IPO was, in my mind, a venous-focused company and exclusively really digging down into that market, looking to change the paradigm of care.

And what we've seen, and what we've heard from you more recently is really an expanding focus and looking to get more about and hear more about that later this week

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot